Wealthcare Capital Management LLC Amgen Inc Transaction History

Wealthcare Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $35,504 - $39,389	-152 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $33,730 - $39,307	152 New	152 $38,000
Q2 2020 Jul 29, 2020	SELL	$197.81 - $242.74 $2,967 - $3,641	-15 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $5,467 - $7,251	-30 Reduced 66.67%	15 $3,000
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $8,514 - $10,944	45 New	45 $11,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $2,710 - $3,168	-16 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $2,700 - $3,017	16	16 $3,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wealthcare Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Capital Management LLC with notifications on news.